NCT07106073

Brief Summary

The goal of this observational study is to evaluate the frequency and characteristics of fever in terminally ill adult patients admitted to the Infectious Diseases Hospice at Luigi Sacco Hospital in Milan. The main questions it aims to answer are:

  • How often does fever occur in terminally ill patients during hospice care?
  • What are the typical features of fever in this population in terms of intensity, duration, possible causes, and treatment strategies?
  • Is there any correlation between the occurrence of fever and patients' clinical characteristics, such as age, sex, BMI, comorbidities, and palliative prognostic scores (PPS and PPI)? Participants will be adult patients (≥18 years) with a life expectancy of more than 24 hours and less than 3 months. During their stay, the following data will be collected:
  • Presence and characteristics of fever (temperature, duration, treatment, suspected cause)
  • Clinical and demographic information (e.g., age, sex, BMI, comorbidities, performance status)
  • Details on hospitalization (e.g., symptom burden, need for palliative sedation, outcome) The study will enroll approximately 250 patients consecutively over a 48-week period. No additional procedures or treatments beyond standard clinical care will be required.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
145

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 27, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2025

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

July 22, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 6, 2025

Completed
Last Updated

August 6, 2025

Status Verified

July 1, 2025

Enrollment Period

3 months

First QC Date

July 22, 2025

Last Update Submit

July 29, 2025

Conditions

Keywords

FeverPalliative CareHospice CareTerminally ill patientsInfectious Diseases Hospice

Outcome Measures

Primary Outcomes (1)

  • Frequency of Fever in Terminally Ill Patients

    Number of patients who develop at least one febrile episode (defined as body temperature \>37.5°C) during their stay in the hospice. Unit of Measure: Number of patients

    48 weeks

Secondary Outcomes (1)

  • Intensity of Fever

    48 weeks

Other Outcomes (9)

  • Duration of Fever

    48 weeks

  • Clinical Correlates of Fever

    48 weeks

  • Length of Stay in Hospice

    48 weeks

  • +6 more other outcomes

Interventions

Data collected is: * demographic data: age, sex; * anthropometric data: weight, height, body mass index; * clinical data: * Palliative Performance Scale; * Palliative Prognostic Index; * comorbidities; * therapy; * presence of medical devices; * presence of pressure injuries; * time on waiting list; * place of care; * primary diagnosis; * length of stay; * symptom burden at admission (Edmonton Symptom Assessment System); * onset of fever and its characteristics (duration, intensity, treatment, etiology); * need for sedation (duration, refractory symptom(s)); * outcome.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be recruited from the Hospice of Infectious Diseases at Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy. The study population includes adult terminally ill patients admitted for end-of-life care.

You may qualify if:

  • Male and female patients;
  • Age ≥ 18 years;
  • Terminally ill patients with an estimated life expectancy between 24 hours and 3 months;
  • Signed informed consent.

You may not qualify if:

  • Patients under 18 years of age;
  • Terminally ill patients with a life expectancy \< 24 hours
  • Non-terminal patients admitted for respite care.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ASST Fatebenefratelli Sacco

Milan, Italia, 20157, Italy

Location

MeSH Terms

Conditions

Fever

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Study coordinator

Study Record Dates

First Submitted

July 22, 2025

First Posted

August 6, 2025

Study Start

March 27, 2025

Primary Completion

June 27, 2025

Study Completion

July 22, 2025

Last Updated

August 6, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations